Delayed rectifier voltage-gated potassium channel (Kv channel)

Delayed rectifier voltage-gated potassium channels are essential transmembrane proteins that facilitate the efflux of potassium ions from neurons in response to membrane depolarization. They are distinguished by a characteristic delay in their activation kinetics, which allows the initial depolarization phase of an action potential to occur before initiating the repolarization phase (PubMed, PMC2268242). By controlling the shape and frequency of action potentials, these channels play a fundamental role in maintaining electrical stability and preventing repetitive firing in the central and peripheral nervous systems (StatPearls, 2023). Mutations in the genes encoding these channels, such as KCNA1 (Kv1.1) or KCNB1 (Kv2.1), are associated with severe neurological conditions including epilepsy, episodic ataxia, and developmental delay (NIH, 2022). Pharmacological agents like 4-aminopyridine are used to block these channels to improve conduction in demyelinated axons, while research into selective activators or blockers continues for the treatment of cognitive deficits and pain (PubChem). However, the high structural similarity between different potassium channel subtypes presents a significant challenge for drug development, often leading to off-target effects in the cardiovascular system (Wikipedia).

Other names

Delayed rectifier K+ channelVoltage-gated potassium channelIK current channelIDR current channelKv1 familyKv2 familyKv3 family

Drugs targeting these channels typically act as pore blockers or gating modifiers that inhibit or enhance the efflux of potassium ions, thereby modulating the duration of the action potential and the refractory period of the neuron (StatPearls, 2023).